Lucid Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
CEOLishan Aklog
CEOLishan Aklog
Employees72
Employees72
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees72
Employees72
LUCD Key Statistics
Market cap122.55M
Market cap122.55M
Price-Earnings ratio-0.84
Price-Earnings ratio-0.84
Dividend yield—
Dividend yield—
Average volume853.29K
Average volume853.29K
High today$1.03
High today$1.03
Low today$0.9495
Low today$0.9495
Open price$1.01
Open price$1.01
Volume729.19K
Volume729.19K
52 Week high$1.80
52 Week high$1.80
52 Week low$0.7201
52 Week low$0.7201
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LUCD. This list is generated using Robinhood data, and it’s not a recommendation.